Effects of the application of anti-rabies vaccine in dogs that were vaccinated during the massive antirabies vaccination campaign in Lima-Peru in 1993
DOI:
https://doi.org/10.21640/ns.v3i6.186Keywords:
serum neutralization, antibody titres, anti-rabies vaccination, anti-rabies protectionAbstract
In this work we determined the immune response after anti-rabies vaccination campaigns massive in 19 districts of the Lima city. The method used was the titration of anti-rabies antibodies by serum neutralization test in mice, a technique that was applied to a significant sample of blood serum of the canine population vaccinated. It took 54 random samples of dogs’ teething rings that joined the Center for Anti-rabies of Lima to be clinically observed for a period of 10 days. Of the 54 serum samples that were tested, 28 (52%) were positive (titres of 0.5-8.39 IU/ml), whereas 26 (48%) remaining samples gave titres below 0.5 IU/ml and others were negative to the test. The age group of the largest sampling counted to population of dogs most risk (1-3 years old). In this age group, 14 dogs (26%) had sera with protection, whereas 18 dogs (33%) the test was negative. With regard to sex, the group of male dogs (considered higher risk) had a greater number of individuals (44 dogs) with respect to the group of females (10 dogs) and only 24 male dogs (45%) gave evidence of protection anti-rabies. In conclusion, we can say that 52% of dogs vaccinated during the previous massive campaigns of vaccination against rabies in Lima in 1993, had protective antibody titers against rabies virus.Downloads
References
Almeida MF, EA Aguilar, LA Martorelli, D Presotto, MM Brendão, OA Pereira. (1997). Resposta imune humoral de cães á vacina inativada, de cérebro de camundongos lactentes, utilizada nas campanhas anti-rábicas no Brasil. Rev Saude Publica 31, 502-07.
Arana HM. (1985). Programa de control de rabia en el área hospitalaria Nº 21 Breña-Jesús María. Informe Nº 1, Hospital Base Arzobispo Loayza. Lima, Perú.
CAL, Centro Antirrábico de Lima. (1982). Informe estadístico de casos de rabia canina y humana. Oficina de estadística del Centro Antirrábico de Lima, Perú.
Chomel B, G Chappuis, F Bullón, E Cárdenas, TD de Beublain, M Lombard, E Giambruno. (1988). Mass vaccination campaign against rabies: are dogs correctly protected? The Peruvian experience. Rev Infect Dis. 10, 697-702.
Chomel BB. (1993). The modern epidemiological aspects of rabies in the world. Comp. Immunol Microbiol Infect Dis. 16, 11-20.
Da Silva LH, CE Bissoto, C Carvalho, TS Cardoso, DM Pinheiro, SH Perri. (2002). Comparison between the counter inmunoelectrophoresis test and mouse neutralization test for the detection of antibodies against rabies virus in dog será. Mem Inst Oswaldo Cruz 97 (2): 259-61.
De Salas C, F Bullón, A Málaga, J Nakajata, A Rodríguez. (1989). Perfil de la rabia en el Perú. Anales del seminario nacional de zoonosis y enfermedades de transmisión alimentaria. MINSA, Lima-Perú, 03-04 de Julio.
Delgado S, P Cármenes. (1997). Immune response following a vaccination campaign against rabies in dogs from northwestern Spain. Prev Vet Med 31, 257-61.
Díaz AM, N Dellepiane, LF Palomo. (1989). Antirabies vaccine from the brain of the suckling rat: Antigen composition and immunogenic capacity. Bol Oficina Sanit Panam 107, 185-95.
Favoretto AR, ML Carrier, MS Tino, A Assis, CR Zanetti, OAC Pereira. (1993). Reduced Schedule of Human Anti-rabies With Fuenzalida & Palacios Vaccine. Rev. Inst. Med. Trop. Sao Paulo. 35, 281-4.
Gutiérrez D. (1955). La Rabia en el Perú. Rev. Med. Hospital Obrero Guillermo Almenara, Instituto Peruano de Seguridad social, Vol. 4.
Hoff GL, GF Mellon, MC Thomas, DH Giendinghagen. (1993). Bats, Cats and rabies in an urban community. South Med. J. 86, 1115-8
López A, P Miranda, E Tejada, DB Fishbein. (1992). Outbreak of human rabies in the Peruvian jungle. Oficina General de Epidemiología. Lancet 339, 408-11.
López R, A Díaz, E Condori. (2007). Susceptibilidad canina a rabia después de una campaña de vacunación en zonas endémicas del Perú. Rev Perú Med Exp Salud Pública. 24 (1): 13-19.
Málaga A. (1970). Informe de Asesoría al Ministerio de Salud para el Programa Piloto de Vacunación Antirrábica Masiva. Informe OPS, Lima-Perú.
Málaga A y E López. (1984). Evolución de la Rabia. Lima-Perú. Bol. Inst. Nac. Salud. 5, 1-40.
MINSA, Ministerio de Salud, Perú. (1985). Evaluación del Programa Nacional de Control de Rabia. Dirección de Salud de las Personas, Lima, 1980-1984. Informe Técnico. Lima.
OPS, Organización Panamericana de la Salud. (1992). Estrategia y plan de acción para la eliminación de la rabia humana en América Latina para el final de la década 1980. Guayaquil.
Rigo L, MR Honer. (2006). Titulaçao de anticorpos contra o virus da raiva em cães, em Campo Grande, MS, na Campanha Anti-Rábica de 2003. Rev Soc Bras Med Trop 39(6): 553-55.
Rodríguez A. (1993). Informe anual de rabia en el Perú. Instituto Nacional de Salud. Boletín informativo. Laboratorio Nacional de Diagnóstico de Rabia. Lima, Perú.
Seghaier C, F Cliquet, S Hammami, T Aouina, M Aubert. (1999). Rabies mass vaccination campaigns in Tunisia: are vaccinated dogs correctly immunized?. Am J Trop Med Hyg 61(6): 879-84.
Szyfres B. (1982). Zoonosis and communicable diseases common to man and animals. World Health Organization. Washington DC. USA.
Valderrama A, A Díaz, R López-Ingunza. (2004). Cobertura inmunológica antirrábica de canes mordedores ingresados al Centro Antirrábico de Lima. Primer Seminario Internacional de Zoonosis y Enfermadades Transmitidas por Alimentos. Lima, MINSA.
Unanue H. (1815). Observaciones sobre el clima de Lima y su influencia en los seres organizados en especial el hombre. Segunda Edición, reconocimiento Real Cédula de 9 de mayo 1915, Virreinato del Perú.
WHO, World Health Organization. (1992). Report of the expert committee on rabies in Ginebra. Tenth report Ginebra: WHO Nº 909.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2015 Nova Scientia
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Conditions for the freedom of publication: the journal, due to its scientific nature, must not have political or institutional undertones to groups that are foreign to the original objective of the same, or its mission, so that there is no censorship derived from the rigorous ruling process.
Due to this, the contents of the articles will be the responsibility of the authors, and once published, the considerations made to the same will be sent to the authors so that they resolve any possible controversies regarding their work.
The complete or partial reproduction of the work is authorized as long as the source is cited.
